Health Catalyst, Inc. (HCAT)
Helps hospitals organize and analyze patient data to improve care and reduce costs.
$2.13-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-39.5%
The outlook
HCAT trades at $2.13, sitting above both its 50- and 200-day moving averages and positioned in the lower third of its 52-week range. Analyst consensus leans Buy, with an average price target about 6% above the current level. The overall data picture leans bullish, though coverage is modest at five analysts.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +6% vs current price
Analyst price target
~12-month · 5 analysts$2.25average target+5.6% vs now
Now $2.13
Low $1.75High $3.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$157.4M
52-wk high
$4.11
52-wk low
$0.96
50-day avg
$1.80
200-day avg
$2.02
Trailing P/E
—